Quantitative Systematic Strategies LLC Axsome Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$68.34 - $85.84 $218,961 - $275,031	-3,204 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$49.87 - $98.69 $24,436 - $48,358	-490 Reduced 13.26%	3,204 $264,000
Q1 2020 May 06, 2020	SELL	$41.2 - $101.31 $92,494 - $227,440	-2,245 Reduced 37.8%	3,694 $217,000
Q4 2019 Feb 11, 2020	SELL	$16.71 - $106.24 $108,832 - $691,941	-6,513 Reduced 52.3%	5,939 $614,000
Q3 2019 Nov 07, 2019	BUY	$20.24 - $29.16 $50,377 - $72,579	2,489 Added 24.98%	12,452 $252,000
Q2 2019 Jul 25, 2019	BUY	$13.46 - $25.75 $134,101 - $256,547	9,963 New	9,963 $257,000

293

40.3M

365K

423K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.9B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.